NCT02323321已完成不适用
International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS™) Heart For Preserving and Assessing Expanded Criteria Donor Hearts for Transplantation (EXPAND Heart Trial)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- TransMedics
- 入组人数
- 75
- 试验地点
- 15
- 主要终点
- Patient Survival at Day-30 Post Transplant and Absence of Severe Primary Heart Graft Dysfunction in the First 24 Hours Post-transplantation
研究概览
简要总结
To evaluate the effectiveness of the OCS™ Heart to recruit, preserve and assess donor hearts that may not meet current standard donor heart acceptance criteria (as identified above) for transplantation to potentially improve donor heart utilization for transplantation
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Registered male or female primary Heart transplant candidate
- •Age ≥18 years old
排除标准
- •Prior solid organ or bone marrow transplant
- •Chronic use of hemodialysis or diagnosis of chronic renal insufficiency
- •Multi-organ transplant
结局指标
主要结局
Patient Survival at Day-30 Post Transplant and Absence of Severe Primary Heart Graft Dysfunction in the First 24 Hours Post-transplantation
时间窗: 30 Days
A composite endpoint of patient survival at Day-30 post-transplant and absence of severe heart primary graft dysfunction (PGD) (left or right ventricle)) in the first 24 hours post-transplantation.
次要结局
未报告次要终点
研究者
研究点 (15)
Loading locations...
相似试验
已完成
不适用
Donors After Circulatory Death Heart TrialHeart TransplantNCT03831048TransMedics180
已完成
不适用
International EXPAND Lung Pivotal TrialLung TransplantNCT01963780TransMedics79
已完成
不适用
Donor After Circulatory Death Heart CAP TrialHeart TransplantNCT04615182TransMedics90
已完成
不适用
Heart EXPAND Continued Access ProtocolHeart TransplantNCT03835754TransMedics75
终止
不适用
OCS Lung System EXPAND II TrialLung TransplantationNCT03343535TransMedics46